PHARMAGEST BELGIUM
ActiveFrom the official registers: KBO 24 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
PHARMAGEST BELGIUM has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€2.8m) and a net result of -€86,260. Equity has been shrinking by about 24% per year since 2018. Its solvency ranks better than 5% of 3,387 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Official details
KBO- Status
- Active since 11-01-2002 Normal situation
- Activity
- Computer consultancy and computer facilities management NACE 62200and 3 others
- Establishment unit
- 2.096.054.786 6041 Charleroi, since 07-06-2002
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Board and ownership
- Denis SUPPLISSONDirector · since 23-05-2025
- Auditor
- AVISOR - Réviseurs d'Entreprises
- SA EQUASENSconsolidatesannual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.3%
- Gross margin
- €1.5m
- ▲ 32.9%
- Turnover
- ≈ €3.6m
- estimated
- Loss
- €86,260
- ▼ 77.0%
- Equity
- -€2.8m
- ▼ 3.1%
- Total assets
- €1.1m
- ▲ 51.7%
- Staff
- 19.6 FTE
- ▲ 4.8%
Score breakdownraises riskCapped at 59: negative equityNegative equity -€2.8mLoss of €86,260, the second in a row (financial year 2025)Size: 19.6 FTE, total assets €1.1mlowers riskSector: Computer programming, consultancy and related activities (NACE 62)Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 62, small). It does better than 2% of them on solvency, 13% on liquidity, 13% on profitability and 26% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 35 days after the deadline. In the sector (NACE 62), the median for financial year 2024 was 9 days before the deadline, and 33% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€2.8m View
- Risk: 8 loss-making years in a rowloss in financial year 2025 -€86,260 View
- Caution: Lower solvency than 95% of companies in computer programming and consultancysector median 46.4% · 3,387 companies -249.9% View
- Positive: Result rose in 2025different schema filed ▲ 77.0% View
Comparable companies
These companies have the same main activity as PHARMAGEST BELGIUM: computer consultancy and computer facilities management (NACE 62200). They are comparable in size and age: total assets between €1m and €1.4m, founded between 1998 and 2007.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMAGEST BELGIUM Charleroi | €1.1m | €1.5m |
| INVENTIS Oudsbergen | €1.0m | €1.6m |
| IT ANYWHERE Zaventem | €1.0m | €1.7m |
| CALLDESK Liège | €1.4m | €1.4m |
| Arcsom Beersel | €1.3m | €1.4m |
| iDA Kontich | €1.4m | €1.8m |
| Bright Dots Kontich | €1.2m | €1.3m |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 05-08-2026
- Annual accounts 2024filed on 21-08-2025
- Annual accounts 2023filed on 30-09-2024
- Annual accounts 2022filed on 31-10-2023
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 07-07-2025
- Resignations & appointmentsact of 04-12-2024
- Legal-form change · Resignations & appointmentsact of 19-03-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about PHARMAGEST BELGIUM
- What is the company number of PHARMAGEST BELGIUM?
- The company number of PHARMAGEST BELGIUM is 0476.626.524. The VAT number is the same number with BE in front: BE 0476.626.524.
- Where is PHARMAGEST BELGIUM based?
- The registered office is at Avenue Georges Lemaitre 58, 6041 Charleroi.Company details
- What does PHARMAGEST BELGIUM do?
- According to the KBO register, the main activity is computer consultancy and computer facilities management (NACE 62200).
- What is the legal form of PHARMAGEST BELGIUM?
- The legal form of PHARMAGEST BELGIUM is Private limited company (BV).
- When was PHARMAGEST BELGIUM founded?
- PHARMAGEST BELGIUM was founded on 11-01-2002.
- Is PHARMAGEST BELGIUM still active?
- Yes, PHARMAGEST BELGIUM is an active enterprise in the KBO register.
- How many employees does PHARMAGEST BELGIUM have?
- PHARMAGEST BELGIUM had an average of 19.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of PHARMAGEST BELGIUM?
- The turnover in financial year 2025 is ≈ €3.6m. This figure is estimated from the gross margin of €1.5m and 117 comparable companies (NACE 62200). It probably lies between €2.8m and €5.2m.
- Is PHARMAGEST BELGIUM profitable?
- In financial year 2025, PHARMAGEST BELGIUM made a loss of €86,260.
- Where can I find the annual accounts of PHARMAGEST BELGIUM?
- PHARMAGEST BELGIUM filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of PHARMAGEST BELGIUM due?
- PHARMAGEST BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.